These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30019947)

  • 1. The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov.
    Barth P; Vale C; Chambers AB; Reagan JL
    Future Oncol; 2018 Aug; 14(19):1965-1976. PubMed ID: 30019947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunotherapy in multiple myeloma: lessons from preclinical models.
    Binsfeld M; Fostier K; Muller J; Baron F; Schots R; Beguin Y; Heusschen R; Caers J
    Biochim Biophys Acta; 2014 Dec; 1846(2):392-404. PubMed ID: 25109893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
    Cook G; Ashcroft AJ; Cairns DA; Williams CD; Brown JM; Cavenagh JD; Snowden JA; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Chown S; Heartin E; O'Connor S; Drayson MT; Hockaday A; Morris TC;
    Lancet Haematol; 2016 Jul; 3(7):e340-51. PubMed ID: 27374467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.
    Rasche L; Duell J; Castro IC; Dubljevic V; Chatterjee M; Knop S; Hensel F; Rosenwald A; Einsele H; Topp MS; Brändlein S
    Haematologica; 2015 Mar; 100(3):377-84. PubMed ID: 25637055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
    Chiriva-Internati M; Cobos E; Kast WM
    Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current role of immunotherapy in multiple myeloma.
    Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
    Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC in multiple myeloma immunotherapy.
    Turtle CJ; Brown RD; Joshua DE; Hart DN
    Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q
    Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
    Thanendrarajan S; Davies FE; Morgan GJ; Schinke C; Mathur P; Heuck CJ; Zangari M; Epstein J; Yaccoby S; Weinhold N; Barlogie B; van Rhee F
    Immunotherapy; 2016; 8(3):367-84. PubMed ID: 26888183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-based targeted immunotherapies for patients with multiple myeloma.
    Wang L; Jin N; Schmitt A; Greiner J; Malcherek G; Hundemer M; Mani J; Hose D; Raab MS; Ho AD; Chen BA; Goldschmidt H; Schmitt M
    Int J Cancer; 2015 Apr; 136(8):1751-68. PubMed ID: 25195787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.
    Nijhof IS; Groen RW; Noort WA; van Kessel B; de Jong-Korlaar R; Bakker J; van Bueren JJ; Parren PW; Lokhorst HM; van de Donk NW; Martens AC; Mutis T
    Clin Cancer Res; 2015 Jun; 21(12):2802-10. PubMed ID: 25398450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite.
    Zibelman M; Barth P; Handorf E; Smaldone MC; Kutikov A; Uzzo RG; Bilusic M; Plimack ER; Wong YN; Geynisman DM
    Clin Genitourin Cancer; 2015 Apr; 13(2):142-9. PubMed ID: 25450029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.
    Lendvai N; Cohen AD; Cho HJ
    Bone Marrow Transplant; 2015 Jun; 50(6):770-80. PubMed ID: 25751647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for multiple myeloma: Current status and future directions.
    Ayed AO; Chang LJ; Moreb JS
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):399-412. PubMed ID: 26153389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The next generation of novel therapies for the management of relapsed multiple myeloma.
    Gonsalves WI; Milani P; Derudas D; Buadi FK
    Future Oncol; 2017 Jan; 13(1):63-75. PubMed ID: 27513456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma.
    Rasche L; Kortüm KM; Raab MS; Weinhold N
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARs in the Lead Against Multiple Myeloma.
    Ormhøj M; Bedoya F; Frigault MJ; Maus MV
    Curr Hematol Malig Rep; 2017 Apr; 12(2):119-125. PubMed ID: 28233151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.
    Holstein SA; Avet-Loiseau H; Hahn T; Ho CM; Lohr JG; Munshi NC; Paiva B; Pasquini MC; Tario JD; Usmani SZ; Wallace PK; Weisel K; McCarthy PL
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):641-648. PubMed ID: 29242112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.